Danazol therapy combined with intermittent application of chemotherapy induces lasting remission in myeloproliferative disorder (MPD): an alternative for the elderly with advanced MPD

Figures & data

Table 1. Data on all patients and subgroup analysis of excellent (E), good (G), and poor (P) responders are shown

		Excellent	Good	Poor
	Total	(E)	(G)	(P)
No.	18	3	8	7
Mean age (years old)	70·6	75	66·4	74
Sex (M/F)	7/11	0/3	3/5	4/3
MPD type	16 MF, 3 ET	3 MF	7 MF, 1ET	6 MF, 1ET
MPD duration (year)	12·6	7·0	16·4	10·3

Note: MF, myelofibrosis; ET, essential thrombocythemia.

Table 2. Data on treatment period and duration of remission of excellent (E), good (G), and poor (P) responders are summarized

	Excellent	Good	Poor
No.	3	8	7
Treatment period (month)	6–30	1–21	1–9
Mean	14	7	4
Remission duration (month)	10–78	2–22	1–15
Mean	45	11	7